Literature DB >> 7583906

Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers.

A Mashberg1, A Samit.   

Abstract

An examination of the oral cavity and oropharynx in asymptomatic patients at high risk requires an orderly visual inspection of the entire oral and oropharyngeal mucosa with particular attention to the tongue, floor of mouth, soft palate, uvula, tonsillar pillars, and the lingual aspects of the retromolar trigones. Completion and clear documentation of the entire examination should be recorded. Detected lesions that do not resolve in a reasonable length of time--two to three weeks--require intense and assiduous investigation. The following specifics should be considered. 1. Alcohol drinkers and cigarette smokers, especially those 40 years of age and older, are at very high risk for the development of upper aerodigestive tract and lung squamous carcinomas. 2. The floor of the mouth, the ventrolateral tongue, and the soft palate complex are the high-risk sites within the oral cavity and oropharynx. 3. Persistent mucosal erythroplasia rather than leukoplakia is the earliest visual sign of oral and oropharyngeal carcinoma. These lesions should not be regarded merely as precancerous changes. The evidence indicates that these lesions in high-risk sites should be considered to be invasive carcinoma or carcinoma in situ unless proven otherwise by biopsy. 4. Toluidine blue staining is a useful diagnostic adjunct, particularly as a method of ruling out false-negative clinical impressions. It may also be used as a rinse in high-risk patients to encompass the entire oral mucosa after a negative clinical examination and as a guide to improve biopsy yields. 5. If oral or oropharyngeal cancer is identified, evaluations of the larynx, hypopharynx, esophagus, and lungs should be performed to rule out multiple primary cancers.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7583906     DOI: 10.3322/canjclin.45.6.328

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  26 in total

1.  Demographics and efficacy of head and neck cancer screening.

Authors:  Andrew G Shuman; Payam Entezami; Anna S Chernin; Nancy E Wallace; Jeremy M G Taylor; Norman D Hogikyan
Journal:  Otolaryngol Head Neck Surg       Date:  2010-09       Impact factor: 3.497

2.  Toluidine blue color perception in identification of oral mucosal lesions.

Authors:  Pelin Güneri; Joel B Epstein; Selin Ergün; Hayal Boyacioğlu
Journal:  Clin Oral Investig       Date:  2010-03-25       Impact factor: 3.573

3.  Unknown internal carotid artery atherosclerotic stenoses detected with biphasic multidetector computed tomography for head and neck cancer.

Authors:  Nicola Flor; Francesco Sardanelli; Simone Soldi; Giuseppe Franceschelli; Caterina Missiroli; Fiora De Paoli; Gianpaolo Cornalba
Journal:  Eur Radiol       Date:  2005-12-01       Impact factor: 5.315

4.  Transition of Immunohistochemical Expression of E-Cadherin and Vimentin from Premalignant to Malignant Lesions of Oral Cavity and Oropharynx.

Authors:  Kafil Akhtar; Anjum Ara; Shahid A Siddiqui; Rana K Sherwani
Journal:  Oman Med J       Date:  2016-05

5.  Addressing tobacco in managed care: a survey of dentists' knowledge, attitudes, and behaviors.

Authors:  David Albert; Angela Ward; Kavita Ahluwalia; Donald Sadowsky
Journal:  Am J Public Health       Date:  2002-06       Impact factor: 9.308

6.  Screening for head and neck cancer in liver transplant candidates: a review of 11 years of experience at the University of Pittsburgh.

Authors:  Raj C Dedhia; Jennifer R Grandis; Paulo A Fontes; Jonas T Johnson; Joel Weissfeld
Journal:  Laryngoscope       Date:  2011-12-19       Impact factor: 3.325

Review 7.  Biomarkers of head and neck cancer, tools or a gordian knot?

Authors:  Evangeli S Lampri; Georgios Chondrogiannis; Elli Ioachim; Anna Varouktsi; Antigoni Mitselou; Aggeliki Galani; Evangelos Briassoulis; Panagiotis Kanavaros; Vasiliki Galani
Journal:  Int J Clin Exp Med       Date:  2015-07-15

8.  A comparative analysis of toluidine blue with frozen section in oral squamous cell carcinoma.

Authors:  Montasir Junaid; Moaz M Choudhary; Zain A Sobani; Ghulam Murtaza; Sadaf Qadeer; Naeem S Ali; Mumtaz J Khan; Anwar Suhail
Journal:  World J Surg Oncol       Date:  2012-04-16       Impact factor: 2.754

Review 9.  Diagnostic modalities for squamous cell carcinoma: an extensive review of literature-considering toluidine blue as a useful adjunct.

Authors:  Naveen Chhabra; Shruti Chhabra; Nitin Sapra
Journal:  J Maxillofac Oral Surg       Date:  2014-07-29

10.  Assessing the accuracy of autofluorescence, chemiluminescence and toluidine blue as diagnostic tools for oral potentially malignant disorders--a clinicopathological evaluation.

Authors:  K H Awan; P R Morgan; S Warnakulasuriya
Journal:  Clin Oral Investig       Date:  2015-03-26       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.